Professor Risteárd Ó Laoide:

I will add as well that some bracket testing is also done to support chemotherapy treatments and since May 2021, there has been an improved indication for a drug called Talazoparib, one of the poly ADP-ribose polymerase, PARP, inhibitors. We now direct germline bracket testing for cancer patients who are bracket positive and may then benefit from this drug. That is now available. That testing is done in St. James's Hospital and Beaumont Hospital.